InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Spetzler David Baxley. Director active across 1 company, notably Caris Life Sciences, Inc.. In total, 9 reports have been recorded. Breakdown: 1 buy · 3 sells. Total volume traded: €12.8m. History available since 3 March 2025. The latest transaction was filed on 3 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Spetzler David Baxley is a declarant linked to Caris Life Sciences, Inc. He appears in 4 filings in total, and the sampled recent filings cover the period from 2025-06-23 to 2026-03-10, with EUR 8260 of buys and EUR 12511676 of sells. The stated modal transaction nature is Attribution.